Related Experiment Videos
[Neonatal morbidity associated with meconial amniotic fluid]
J González de Dios1, M Moya Benavent, A Barbal Rodoreda
1Departamento de Pediatría, Hospital Universitario San Juan, Alicante.
Anales Espanoles De Pediatria
|May 15, 1998
Summary
Thick meconium-stained amniotic fluid (MSAF) is associated with increased neonatal morbidity, particularly when linked to perinatal asphyxia. This finding highlights thick meconium as a risk factor impacting infant well-being during and after birth.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Perinatal Health
Context:
- Meconium-stained amniotic fluid (MSAF) is a significant obstetric finding.
- Concerns include fetal distress, perinatal asphyxia, and meconium aspiration syndrome.
- Understanding MSAF's impact on neonatal outcomes is crucial for clinical management.
Purpose:
- To determine the incidence and types of MSAF.
- To investigate neonatal morbidity associated with MSAF in admitted newborns.
- To analyze perinatal differences between moderate and thick MSAF.
Summary:
- MSAF complicates 18% of deliveries; 10.8% mild, 4.4% moderate, 2.8% severe.
- One-third of MSAF neonates admitted to the Neonatal Care Unit (NCU) for perinatal asphyxia or risk of meconium aspiration syndrome.
- Neonatal morbidities included perinatal asphyxia (56.1%), pulmonary pathology (34%), and gastrointestinal pathology (30.5%).
- Thick meconium and associated perinatal asphyxia significantly increase neonatal morbidity.
Impact:
- Thick meconium is identified as a risk factor for adverse intrapartum and postpartum outcomes.
- Findings underscore the importance of monitoring and managing MSAF, especially in its severe forms.
- This research informs obstetric and pediatric care strategies for neonates exposed to MSAF.